Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New developments in the treatment of osteoporosis.
Eriksen EF, Halse J, Moen MH. Eriksen EF, et al. Among authors: halse j. Acta Obstet Gynecol Scand. 2013 Jun;92(6):620-36. doi: 10.1111/j.1600-0412.2012.01473.x. Acta Obstet Gynecol Scand. 2013. PMID: 22646526 Free article. Review.
[When should bisphosphonate treatment be discontinued?].
Eriksen EF, Halse J. Eriksen EF, et al. Among authors: halse j. Tidsskr Nor Laegeforen. 2012 Aug 7;132(14):1630-2. doi: 10.4045/tidsskr.11.0788. Tidsskr Nor Laegeforen. 2012. PMID: 22875131 Free article. Norwegian. No abstract available.
[Denosumab for treatment of postmenopausal osteoporosis].
Syversen U, Halse JI, Geisler J, Eriksen EF. Syversen U, et al. Among authors: halse ji. Tidsskr Nor Laegeforen. 2011 Oct 4;131(19):1893-6. doi: 10.4045/tidsskr.10.1116. Tidsskr Nor Laegeforen. 2011. PMID: 21984295 Free article. Review. Norwegian.
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, García-Hernandez PA, Supronik J, Lewiecki EM, Ochoa L, Miller P, Hu H, Mesenbrink P, Hartl F, Gasser J, Eriksen EF. Recker RR, et al. Among authors: halse j. J Bone Miner Res. 2008 Jan;23(1):6-16. doi: 10.1359/jbmr.070906. J Bone Miner Res. 2008. PMID: 17892374 Free article. Clinical Trial.
Consensus development statement on osteoporosis.
Sørensen OH, Nielsen SP, Charles P, Eriksen EF, Mosekilde L, Heaney RP, Falch J, Halse J, Haug E. Sørensen OH, et al. Among authors: halse j. Osteoporos Int. 1997;7(6):589. doi: 10.1007/BF02652567. Osteoporos Int. 1997. PMID: 9604057 No abstract available.
Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.
Eastell R, Lang T, Boonen S, Cummings S, Delmas PD, Cauley JA, Horowitz Z, Kerzberg E, Bianchi G, Kendler D, Leung P, Man Z, Mesenbrink P, Eriksen EF, Black DM; HORIZON Pivotal Fracture Trial. Eastell R, et al. Osteoporos Int. 2010 Jul;21(7):1277-85. doi: 10.1007/s00198-009-1077-9. Epub 2009 Oct 3. Osteoporos Int. 2010. PMID: 19802508 Free PMC article. Clinical Trial.
A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis.
Halse J, Greenspan S, Cosman F, Ellis G, Santora A, Leung A, Heyden N, Samanta S, Doleckyj S, Rosenberg E, Denker AE. Halse J, et al. J Clin Endocrinol Metab. 2014 Nov;99(11):E2207-15. doi: 10.1210/jc.2013-4009. Epub 2014 Aug 28. J Clin Endocrinol Metab. 2014. PMID: 25166719 Free PMC article. Clinical Trial.
134 results